Cargando…
Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia
BACKGROUND: Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens. OBJECTIVE: The goal of this study was to deter...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033285/ https://www.ncbi.nlm.nih.gov/pubmed/35464038 http://dx.doi.org/10.3389/fnut.2022.873900 |
_version_ | 1784692851175587840 |
---|---|
author | Kucha, Winner Seifu, Daniel Tirsit, Abenezer Yigeremu, Mahlet Abebe, Markos Hailu, Dawit Tsehay, Dareskedar Genet, Solomon |
author_facet | Kucha, Winner Seifu, Daniel Tirsit, Abenezer Yigeremu, Mahlet Abebe, Markos Hailu, Dawit Tsehay, Dareskedar Genet, Solomon |
author_sort | Kucha, Winner |
collection | PubMed |
description | BACKGROUND: Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens. OBJECTIVE: The goal of this study was to determine the levels of folate, vitamin B12, and homocysteine in the blood of women who had a pregnancy impacted by NTDs. SUBJECTS AND METHODS: A hospital-based case–control study was undertaken between September 2019 and August 2020. The study comprised a total of 100 cases and 167 controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of folate, vitamin B12, and homocysteine in the serum. RESULTS: Only 39% of the cases and 54.5% of control mothers reported periconceptional use of folic acid/multivitamin, which indicated a statistically significant difference (p = 0.014). Logistic regression indicated that periconceptional use of folic acid/multivitamin was associated with NTDs (p = 0.015, OR = 1.873, 95% CI: 1.131–3.101). We found that 57% of the cases and 33.5% of controls, as well as 43% of cases and 20.4% of controls had serum folate and vitamin B12 levels below the cut-off value, respectively. Twenty-seven percent of the cases and 6.6% of controls had hyperhomocysteinemia (HHcy). The median concentrations of folate, vitamin B12, and homocysteine in cases and controls were 4.78 and 8.86 ng/ml; 266.23 and 455 pg/ml; 13.43 and 9.7 μmol/l, respectively. The median concentration of folate (p < 0.001) and vitamin B12 (p < 0.001) were significantly lower in the cases than controls, while the homocysteine concentration (p < 0.001) was significantly lower in the controls than cases. Folate [OR (95% CI) = 1.652 (1.226–2.225; p = 0.001)], vitamin B12 [OR (95% CI) = 1.890 (1.393–2.565; p < 0.001], and homocysteine [OR (95% CI) = 0.191 (0.09–0.405; p < 0.001)] levels were associated with NTDs. CONCLUSION: Folate and vitamin B12 are deficient in both cases and control mothers. The lower levels of folate and vitamin B12 with an elevated homocysteine level in NTD-affected pregnancy may be an indication that these biochemical variables were risk factors for NTDs. Folate/multivitamin supplementation and/or food fortification should be promoted. |
format | Online Article Text |
id | pubmed-9033285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90332852022-04-23 Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia Kucha, Winner Seifu, Daniel Tirsit, Abenezer Yigeremu, Mahlet Abebe, Markos Hailu, Dawit Tsehay, Dareskedar Genet, Solomon Front Nutr Nutrition BACKGROUND: Neural tube defects (NTDs) are prevalent congenital defects associated with pre-pregnancy diet with low levels of maternal folate. They are linked to severe morbidity, disability, and mortality, as well as psychological and economic burdens. OBJECTIVE: The goal of this study was to determine the levels of folate, vitamin B12, and homocysteine in the blood of women who had a pregnancy impacted by NTDs. SUBJECTS AND METHODS: A hospital-based case–control study was undertaken between September 2019 and August 2020. The study comprised a total of 100 cases and 167 controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of folate, vitamin B12, and homocysteine in the serum. RESULTS: Only 39% of the cases and 54.5% of control mothers reported periconceptional use of folic acid/multivitamin, which indicated a statistically significant difference (p = 0.014). Logistic regression indicated that periconceptional use of folic acid/multivitamin was associated with NTDs (p = 0.015, OR = 1.873, 95% CI: 1.131–3.101). We found that 57% of the cases and 33.5% of controls, as well as 43% of cases and 20.4% of controls had serum folate and vitamin B12 levels below the cut-off value, respectively. Twenty-seven percent of the cases and 6.6% of controls had hyperhomocysteinemia (HHcy). The median concentrations of folate, vitamin B12, and homocysteine in cases and controls were 4.78 and 8.86 ng/ml; 266.23 and 455 pg/ml; 13.43 and 9.7 μmol/l, respectively. The median concentration of folate (p < 0.001) and vitamin B12 (p < 0.001) were significantly lower in the cases than controls, while the homocysteine concentration (p < 0.001) was significantly lower in the controls than cases. Folate [OR (95% CI) = 1.652 (1.226–2.225; p = 0.001)], vitamin B12 [OR (95% CI) = 1.890 (1.393–2.565; p < 0.001], and homocysteine [OR (95% CI) = 0.191 (0.09–0.405; p < 0.001)] levels were associated with NTDs. CONCLUSION: Folate and vitamin B12 are deficient in both cases and control mothers. The lower levels of folate and vitamin B12 with an elevated homocysteine level in NTD-affected pregnancy may be an indication that these biochemical variables were risk factors for NTDs. Folate/multivitamin supplementation and/or food fortification should be promoted. Frontiers Media S.A. 2022-04-08 /pmc/articles/PMC9033285/ /pubmed/35464038 http://dx.doi.org/10.3389/fnut.2022.873900 Text en Copyright © 2022 Kucha, Seifu, Tirsit, Yigeremu, Abebe, Hailu, Tsehay and Genet. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Kucha, Winner Seifu, Daniel Tirsit, Abenezer Yigeremu, Mahlet Abebe, Markos Hailu, Dawit Tsehay, Dareskedar Genet, Solomon Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title | Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title_full | Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title_fullStr | Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title_full_unstemmed | Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title_short | Folate, Vitamin B12, and Homocysteine Levels in Women With Neural Tube Defect-Affected Pregnancy in Addis Ababa, Ethiopia |
title_sort | folate, vitamin b12, and homocysteine levels in women with neural tube defect-affected pregnancy in addis ababa, ethiopia |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033285/ https://www.ncbi.nlm.nih.gov/pubmed/35464038 http://dx.doi.org/10.3389/fnut.2022.873900 |
work_keys_str_mv | AT kuchawinner folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT seifudaniel folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT tirsitabenezer folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT yigeremumahlet folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT abebemarkos folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT hailudawit folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT tsehaydareskedar folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia AT genetsolomon folatevitaminb12andhomocysteinelevelsinwomenwithneuraltubedefectaffectedpregnancyinaddisababaethiopia |